世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

NA遠隔患者モニタリング・ケア市場 - 2030年までの産業動向と予測


NA Remote Patient Monitoring and Care Market - Industry Trends and Forecast to 2030

北米の遠隔患者モニタリング・ケア市場は、2022年の52億2,439万米ドルから2030年には130億2,984万米ドルに達し、2023年から2030年の予測期間中に年平均成長率13.1％で成長すると予測されている。 市場区分 北... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Data Bridge Market Research
データブリッジマーケットリサーチ 		2023年5月1日 US$3,500
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		162 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

北米の遠隔患者モニタリング・ケア市場は、2022年の52億2,439万米ドルから2030年には130億2,984万米ドルに達し、2023年から2030年の予測期間中に年平均成長率13.1％で成長すると予測されている。

市場区分
北米の遠隔患者モニタリング・ケア市場：デバイスタイプ別（心臓モニタリングデバイス、血圧モニタリングデバイス、血糖モニタリングデバイス、呼吸モニタリングデバイス、神経モニタリングデバイス、マルチパラメータモニタリングデバイス、その他）、用途別（腫瘍学、糖尿病、心血管疾患、その他）、エンドユーザー別（病院ベース患者、外来患者、在宅医療患者）、国別（米国、カナダ、メキシコ）-産業動向と2030年までの予測


北米アカウントの遠隔患者モニタリングとケア市場ダイナミクスの概要

促進要因
- 慢性疾患の増加

抑制要因

- 厳しい規制の枠組み

機会

- 市場プレーヤーによる戦略的イニシアティブ

市場プレイヤー

北米の遠隔患者モニタリング・ケア市場で事業を展開する主な市場プレイヤーを以下に挙げる：
- メドトロニック
- ボストン・サイエンティフィック社
- バイタルコネクト
- バイオビート
- ゼネラル・エレクトリック
- フィリップスN.V.
- オムロン株式会社
- アボット
- 日本光電工業株式会社
- ビビファイヘルス株式会社
- アエロテル・メディカル・システムズ
- BIOTRONIK SE & Co.KG
- エー・アンド・デイ株式会社
- アライブコア社
- マシモ
- デックスコム社
- センスオニクス社
- レスメッド
- 100プラス
- クロニセンスメディカル
- ヴィトルス
- カルディオモ
- コーチケア
- ネティエラ
- ウィジングス


ページTOPに戻る


目次

TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW 26
1.4 LIMITATIONS 28
1.5 MARKETS COVERED 28
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GEOGRAPHICAL SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 CURRENCY AND PRICING 32
2.5 DBMR TRIPOD DATA VALIDATION MODEL 33
2.6 MULTIVARIATE MODELLING 36
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 36
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 37
2.9 DBMR MARKET POSITION GRID 38
2.10 MARKET APPLICATION COVERAGE GRID 39
2.11 VENDOR SHARE ANALYSIS 40
2.12 SECONDARY SOURCES 41
2.13 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 PORTER’S FIVE FORCES 46
4.2 VALUE CHAIN ANALYSIS: 47
4.3 COMPETITIVE ANALYSIS 48
4.4 BRAND ANALYSIS 50
4.5 ECOSYSTEM MAPS 51
4.6 TECHNOLOGICAL TRENDS 52
4.7 TOP WINNING STRATEGIES 53
5 MARKET OVERVIEW 54
5.1 DRIVERS 56
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 56
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 56
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 58
5.1.4 INCREASING GOVERNMENT INITIATIVES 58
5.2 RESTRAINTS 59
5.2.1 STRICT REGULATORY FRAMEWORK 59
5.2.2 LACK OF STANDARDIZATION 60
5.3 OPPORTUNITIES 60
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 60
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 61
5.4 CHALLENGES 62
5.4.1 LACK OF SKILLED PROFESSIONALS 62
5.4.2 RISK TO PATIENT'S DATA SECURITY 62
6 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 64
6.1 OVERVIEW 65
6.2 CARDIAC MONITORING DEVICES 68
6.3 BLOOD PRESSURE MONITORING DEVICES 69
6.4 MULTI-PARAMETER MONITORING DEVICES 70
6.5 BLOOD GLUCOSE MONITORING DEVICES 71
6.6 RESPIRATORY MONITORING DEVICES 72
6.7 NEUROLOGICAL MONITORING DEVICES 73
6.8 OTHERS 74
7 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 75
7.1 OVERVIEW 76
7.2 CARDIOVASCULAR DISEASE 79
7.2.1 CORONARY HEART DISEASE 80
7.2.2 STROKE 80
7.2.3 PERIPHERAL ARTERIAL DISEASE 80
7.2.4 AORTIC DISEASE 80
7.2.5 OTHERS 80
7.3 DIABETES 80
7.4 ONCOLOGY 81
7.5 OTHERS 82
8 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 83
8.1 OVERVIEW 84
8.2 HOME HEALTHCARE PATIENTS 87
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 88
8.2.2 CARDIAC MONITORING DEVICES 88
8.2.3 BLOOD PRESSURE MONITORING DEVICES 88
8.2.4 MULTI-PARAMETER MONITORING DEVICES 88
8.2.5 RESPIRATORY MONITORING DEVICES 88
8.2.6 NEUROLOGICAL MONITORING DEVICES 88
8.2.7 OTHERS 89
8.3 AMBULATORY PATIENTS 89
8.3.1 MULTI-PARAMETER MONITORING DEVICES 90
8.3.2 RESPIRATORY MONITORING DEVICES 90
8.3.3 CARDIAC MONITORING DEVICES 90
8.3.4 BLOOD PRESSURE MONITORING DEVICES 90
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 90
8.3.6 NEUROLOGICAL MONITORING DEVICES 90
8.3.7 OTHERS 91
8.4 HOSPITAL-BASED PATIENTS 91
8.4.1 MULTI-PARAMETER MONITORING DEVICES 92
8.4.2 CARDIAC MONITORING DEVICES 92
8.4.3 RESPIRATORY MONITORING DEVICES 92
8.4.4 BLOOD PRESSURE MONITORING DEVICES 92
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 92
8.4.6 NEUROLOGICAL MONITORING DEVICES 92
8.4.7 OTHERS 93
9 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 94
9.1 NORTH AMERICA 95
9.1.1 U.S. 103
9.1.2 CANADA 107
9.1.3 MEXICO 111
10 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 115
10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 115
11 SWOT ANALYSIS 116
12 COMPANY PROFILE 117
12.1 MEDTRONIC 117
12.1.1 COMPANY SNAPSHOT 117
12.1.2 REVENUE ANALYSIS 118
12.1.3 COMPANY SHARE ANALYSIS 118
12.1.4 PRODUCT PORTFOLIO 119
12.1.5 RECENT DEVELOPMENT 119
12.2 DEXCOM, INC. 120
12.2.1 COMPANY SNAPSHOT 120
12.2.2 REVENUE ANALYSIS 120
12.2.3 COMPANY SHARE ANALYSIS 121
12.2.4 PRODUCT PORTFOLIO 121
12.2.5 RECENT DEVELOPMENT 121
12.3 ABBOTT 122
12.3.1 COMPANY SNAPSHOT 122
12.3.2 REVENUE ANALYSIS 122
12.3.3 COMPANY SHARE ANALYSIS 123
12.3.4 PRODUCT PORTFOLIO 123
12.3.5 RECENT DEVELOPMENT 123
12.4 RESMED 124
12.4.1 COMPANY SNAPSHOT 124
12.4.2 REVENUE ANALYSIS 124
12.4.3 COMPANY SHARE ANALYSIS 125
12.4.4 PRODUCT PORTFOLIO 125
12.4.5 RECENT DEVELOPMENT 125
12.5 BIOTRONIK SE & CO. KG 126
12.5.1 COMPANY SNAPSHOT 126
12.5.2 COMPANY SHARE ANALYSIS 126
12.5.3 PRODUCT PORTFOLIO 127
12.5.4 RECENT DEVELOPMENT 127
12.6 100 PLUS. 128
12.6.1 COMPANY SNAPSHOT 128
12.6.2 PRODUCT PORTFOLIO 128
12.6.3 RECENT DEVELOPMENTS 128
12.7 A&D COMPANY, LIMITED 129
12.7.1 COMPANY SNAPSHOT 129
12.7.2 REVENUE ANALYSIS 129
12.7.3 COMPANY SHARE ANALYSIS 130
12.7.4 PRODUCT PORTFOLIO 130
12.7.5 RECENT DEVELOPMENT 130
12.8 AEROTEL MEDICAL SYSTEMS 131
12.8.1 COMPANY SNAPSHOT 131
12.8.2 PRODUCT PORTFOLIO 131
12.8.3 RECENT DEVELOPMENT 131
12.9 ALIVECOR, INC. 132
12.9.1 COMPANY SNAPSHOT 132
12.9.2 COMPANY SHARE ANALYSIS 132
12.9.3 PRODUCT PORTFOLIO 132
12.9.4 RECENT DEVELOPMENTS 133
12.10 BIOBEAT 134
12.10.1 COMPANY SNAPSHOT 134
12.10.2 PRODUCT PORTFOLIO 134
12.10.3 RECENT DEVELOPMENT 134
12.11 BOSTON SCIENTIFIC CORPORATION 135
12.11.1 COMPANY SNAPSHOT 135
12.11.2 REVENUE ANALYSIS 136
12.11.3 COMPANY SHARE ANALYSIS 136
12.11.4 PRODUCT PORTFOLIO 136
12.11.5 RECENT DEVELOPMENT 137
12.12 CARDIOMO 138
12.12.1 COMPANY SNAPSHOT 138
12.12.2 PRODUCT PORTFOLIO 138
12.12.3 RECENT DEVELOPMENTS 138
12.13 CHRONISENSE MEDICAL, LTD. 139
12.13.1 COMPANY SNAPSHOT 139
12.13.2 PRODUCT PORTFOLIO 139
12.13.3 RECENT DEVELOPMENT 139
12.14 COACHCARE 140
12.14.1 COMPANY SNAPSHOT 140
12.14.2 PRODUCT PORTFOLIO 140
12.14.3 RECENT DEVELOPMENT 140
12.15 GENERAL ELECTRIC 141
12.15.1 COMPANY SNAPSHOT 141
12.15.2 REVENUE ANALYSIS 141
12.15.3 COMPANY SHARE ANALYSIS 142
12.15.4 PRODUCT PORTFOLIO 142
12.15.5 RECENT DEVELOPMENT 142
12.16 KONINKLIJKE PHILIPS N.V. 143
12.16.1 COMPANY SNAPSHOT 143
12.16.2 REVENUE ANALYSIS 143
12.16.3 COMPANY SHARE ANALYSIS 144
12.16.4 PRODUCT PORTFOLIO 144
12.16.5 RECENT DEVELOPMENT 144
12.17 MASIMO 145
12.17.1 COMPANY SNAPSHOT 145
12.17.2 REVENUE ANALYSIS 145
12.17.3 COMPANY SHARE ANALYSIS 146
12.17.4 PRODUCT PORTFOLIO 146
12.17.5 RECENT DEVELOPMENT 146
12.18 NETEERA 147
12.18.1 COMPANY SNAPSHOT 147
12.18.2 PRODUCT PORTFOLIO 147
12.18.3 RECENT DEVELOPMENT 147
12.19 NIHON KOHDEN CORPORATION 148
12.19.1 COMPANY SNAPSHOT 148
12.19.2 REVENUE ANALYSIS 148
12.19.3 COMPANY SHARE ANALYSIS 149
12.19.4 PRODUCT PORTFOLIO 149
12.19.5 RECENT DEVELOPMENT 149
12.20 OMRON CORPORATION 150
12.20.1 COMPANY SNAPSHOT 150
12.20.2 REVENUE ANALYSIS 150
12.20.3 COMPANY SHARE ANALYSIS 151
12.20.4 PRODUCT PORTFOLIO 151
12.20.5 RECENT DEVELOPMENT 151
12.21 SENSEONICS, INC. 152
12.21.1 COMPANY SNAPSHOT 152
12.21.2 REVENUE ANALYSIS 152
12.21.3 COMPANY SHARE ANALYSIS 153
12.21.4 PRODUCT PORTFOLIO 153
12.21.5 RECENT DEVELOPMENT 153
12.22 VITALCONNECT 154
12.22.1 COMPANY SNAPSHOT 154
12.22.2 PRODUCT PORTFOLIO 154
12.22.3 RECENT DEVELOPMENT 154
12.23 VITLS 155
12.23.1 COMPANY SNAPSHOT 155
12.23.2 PRODUCT PORTFOLIO 155
12.23.3 RECENT DEVELOPMENT 155
12.24 VIVIFY HEALTH INC. 156
12.24.1 COMPANY SNAPSHOT 156
12.24.2 PRODUCT PORTFOLIO 156
12.24.3 RECENT DEVELOPMENTS 156
12.25 WITHINGS 157
12.25.1 COMPANY SNAPSHOT 157
12.25.2 COMPANY SHARE ANALYSIS 157
12.25.3 PRODUCT PORTFOLIO 157
12.25.4 RECENT DEVELOPMENT 158
13 QUESTIONNAIRE 159
14 RELATED REPORTS 162

　

ページTOPに戻る


　

Summary

The North America remote patient monitoring and care market is expected to reach USD 13,029.84 million by 2030 from USD 5,224.39 million in 2022, growing at a CAGR of 13.1% during the forecast period of 2023 to 2030.

Market Segmentation
North America Remote Patient Monitoring and Care Market, By Device Type (Cardiac Monitoring Devices, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, Respiratory Monitoring Devices, Neurological Monitoring Devices, Multi-Parameter Monitoring Devices, and Others), Application (Oncology, Diabetes, Cardiovascular Diseases, and Others), End User (Hospital Based Patients, Ambulatory Patients, and Home Healthcare Patients), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030


Overview of North America Accounts Remote Patient Monitoring and Care Market Dynamics

Driver
• Increasing prevalence of chronic diseases

Restraint

• Stringent regulatory framework

Opportunity

• Strategic initiatives by market players

Market Players

Some of the major market players operating in the North America remote patient monitoring and care market are:
• Medtronic
• Boston Scientific Corporation
• VitalConnect
• Biobeat
• General Electric
• Koninklijke Philips N.V.
• OMRON Corporation
• Abbott
• Nihon Kohden Corporation
• Vivify Health, Inc.
• Aerotel Medical Systems
• BIOTRONIK SE & Co. KG
• A&D Company, Limited
• AliveCor, Inc.
• Masimo
• Dexcom, Inc.
• Senseonics, Inc.
• ResMed
• 100Plus.
• ChroniSense Medical, Ltd.
• Vitls
• Cardiomo
• CoachCare
• neteera
• Withings



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 26
1.1 OBJECTIVES OF THE STUDY 26
1.2 MARKET DEFINITION 26
1.3 OVERVIEW 26
1.4 LIMITATIONS 28
1.5 MARKETS COVERED 28
2 MARKET SEGMENTATION 30
2.1 MARKETS COVERED 30
2.2 GEOGRAPHICAL SCOPE 31
2.3 YEARS CONSIDERED FOR THE STUDY 32
2.4 CURRENCY AND PRICING 32
2.5 DBMR TRIPOD DATA VALIDATION MODEL 33
2.6 MULTIVARIATE MODELLING 36
2.7 CARDIAC MONITORING DEVICES LIFELINE CURVE 36
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 37
2.9 DBMR MARKET POSITION GRID 38
2.10 MARKET APPLICATION COVERAGE GRID 39
2.11 VENDOR SHARE ANALYSIS 40
2.12 SECONDARY SOURCES 41
2.13 ASSUMPTIONS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 PORTER’S FIVE FORCES 46
4.2 VALUE CHAIN ANALYSIS: 47
4.3 COMPETITIVE ANALYSIS 48
4.4 BRAND ANALYSIS 50
4.5 ECOSYSTEM MAPS 51
4.6 TECHNOLOGICAL TRENDS 52
4.7 TOP WINNING STRATEGIES 53
5 MARKET OVERVIEW 54
5.1 DRIVERS 56
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES 56
5.1.2 GROWTH IN TECHNOLOGICAL ADVANCEMENTS 56
5.1.3 INCREASING DEMAND FOR REMOTE PATIENT MONITORING 58
5.1.4 INCREASING GOVERNMENT INITIATIVES 58
5.2 RESTRAINTS 59
5.2.1 STRICT REGULATORY FRAMEWORK 59
5.2.2 LACK OF STANDARDIZATION 60
5.3 OPPORTUNITIES 60
5.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS 60
5.3.2 PROVIDES QUICK AND REAL TIME RESULTS 61
5.4 CHALLENGES 62
5.4.1 LACK OF SKILLED PROFESSIONALS 62
5.4.2 RISK TO PATIENT'S DATA SECURITY 62
6 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY DEVICE TYPE 64
6.1 OVERVIEW 65
6.2 CARDIAC MONITORING DEVICES 68
6.3 BLOOD PRESSURE MONITORING DEVICES 69
6.4 MULTI-PARAMETER MONITORING DEVICES 70
6.5 BLOOD GLUCOSE MONITORING DEVICES 71
6.6 RESPIRATORY MONITORING DEVICES 72
6.7 NEUROLOGICAL MONITORING DEVICES 73
6.8 OTHERS 74
7 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY APPLICATION 75
7.1 OVERVIEW 76
7.2 CARDIOVASCULAR DISEASE 79
7.2.1 CORONARY HEART DISEASE 80
7.2.2 STROKE 80
7.2.3 PERIPHERAL ARTERIAL DISEASE 80
7.2.4 AORTIC DISEASE 80
7.2.5 OTHERS 80
7.3 DIABETES 80
7.4 ONCOLOGY 81
7.5 OTHERS 82
8 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY END USER 83
8.1 OVERVIEW 84
8.2 HOME HEALTHCARE PATIENTS 87
8.2.1 BLOOD GLUCOSE MONITORING DEVICES 88
8.2.2 CARDIAC MONITORING DEVICES 88
8.2.3 BLOOD PRESSURE MONITORING DEVICES 88
8.2.4 MULTI-PARAMETER MONITORING DEVICES 88
8.2.5 RESPIRATORY MONITORING DEVICES 88
8.2.6 NEUROLOGICAL MONITORING DEVICES 88
8.2.7 OTHERS 89
8.3 AMBULATORY PATIENTS 89
8.3.1 MULTI-PARAMETER MONITORING DEVICES 90
8.3.2 RESPIRATORY MONITORING DEVICES 90
8.3.3 CARDIAC MONITORING DEVICES 90
8.3.4 BLOOD PRESSURE MONITORING DEVICES 90
8.3.5 BLOOD GLUCOSE MONITORING DEVICES 90
8.3.6 NEUROLOGICAL MONITORING DEVICES 90
8.3.7 OTHERS 91
8.4 HOSPITAL-BASED PATIENTS 91
8.4.1 MULTI-PARAMETER MONITORING DEVICES 92
8.4.2 CARDIAC MONITORING DEVICES 92
8.4.3 RESPIRATORY MONITORING DEVICES 92
8.4.4 BLOOD PRESSURE MONITORING DEVICES 92
8.4.5 BLOOD GLUCOSE MONITORING DEVICES 92
8.4.6 NEUROLOGICAL MONITORING DEVICES 92
8.4.7 OTHERS 93
9 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, BY REGION 94
9.1 NORTH AMERICA 95
9.1.1 U.S. 103
9.1.2 CANADA 107
9.1.3 MEXICO 111
10 NORTH AMERICA REMOTE PATIENT MONITORING AND CARE MARKET, COMPANY LANDSCAPE 115
10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 115
11 SWOT ANALYSIS 116
12 COMPANY PROFILE 117
12.1 MEDTRONIC 117
12.1.1 COMPANY SNAPSHOT 117
12.1.2 REVENUE ANALYSIS 118
12.1.3 COMPANY SHARE ANALYSIS 118
12.1.4 PRODUCT PORTFOLIO 119
12.1.5 RECENT DEVELOPMENT 119
12.2 DEXCOM, INC. 120
12.2.1 COMPANY SNAPSHOT 120
12.2.2 REVENUE ANALYSIS 120
12.2.3 COMPANY SHARE ANALYSIS 121
12.2.4 PRODUCT PORTFOLIO 121
12.2.5 RECENT DEVELOPMENT 121
12.3 ABBOTT 122
12.3.1 COMPANY SNAPSHOT 122
12.3.2 REVENUE ANALYSIS 122
12.3.3 COMPANY SHARE ANALYSIS 123
12.3.4 PRODUCT PORTFOLIO 123
12.3.5 RECENT DEVELOPMENT 123
12.4 RESMED 124
12.4.1 COMPANY SNAPSHOT 124
12.4.2 REVENUE ANALYSIS 124
12.4.3 COMPANY SHARE ANALYSIS 125
12.4.4 PRODUCT PORTFOLIO 125
12.4.5 RECENT DEVELOPMENT 125
12.5 BIOTRONIK SE & CO. KG 126
12.5.1 COMPANY SNAPSHOT 126
12.5.2 COMPANY SHARE ANALYSIS 126
12.5.3 PRODUCT PORTFOLIO 127
12.5.4 RECENT DEVELOPMENT 127
12.6 100 PLUS. 128
12.6.1 COMPANY SNAPSHOT 128
12.6.2 PRODUCT PORTFOLIO 128
12.6.3 RECENT DEVELOPMENTS 128
12.7 A&D COMPANY, LIMITED 129
12.7.1 COMPANY SNAPSHOT 129
12.7.2 REVENUE ANALYSIS 129
12.7.3 COMPANY SHARE ANALYSIS 130
12.7.4 PRODUCT PORTFOLIO 130
12.7.5 RECENT DEVELOPMENT 130
12.8 AEROTEL MEDICAL SYSTEMS 131
12.8.1 COMPANY SNAPSHOT 131
12.8.2 PRODUCT PORTFOLIO 131
12.8.3 RECENT DEVELOPMENT 131
12.9 ALIVECOR, INC. 132
12.9.1 COMPANY SNAPSHOT 132
12.9.2 COMPANY SHARE ANALYSIS 132
12.9.3 PRODUCT PORTFOLIO 132
12.9.4 RECENT DEVELOPMENTS 133
12.10 BIOBEAT 134
12.10.1 COMPANY SNAPSHOT 134
12.10.2 PRODUCT PORTFOLIO 134
12.10.3 RECENT DEVELOPMENT 134
12.11 BOSTON SCIENTIFIC CORPORATION 135
12.11.1 COMPANY SNAPSHOT 135
12.11.2 REVENUE ANALYSIS 136
12.11.3 COMPANY SHARE ANALYSIS 136
12.11.4 PRODUCT PORTFOLIO 136
12.11.5 RECENT DEVELOPMENT 137
12.12 CARDIOMO 138
12.12.1 COMPANY SNAPSHOT 138
12.12.2 PRODUCT PORTFOLIO 138
12.12.3 RECENT DEVELOPMENTS 138
12.13 CHRONISENSE MEDICAL, LTD. 139
12.13.1 COMPANY SNAPSHOT 139
12.13.2 PRODUCT PORTFOLIO 139
12.13.3 RECENT DEVELOPMENT 139
12.14 COACHCARE 140
12.14.1 COMPANY SNAPSHOT 140
12.14.2 PRODUCT PORTFOLIO 140
12.14.3 RECENT DEVELOPMENT 140
12.15 GENERAL ELECTRIC 141
12.15.1 COMPANY SNAPSHOT 141
12.15.2 REVENUE ANALYSIS 141
12.15.3 COMPANY SHARE ANALYSIS 142
12.15.4 PRODUCT PORTFOLIO 142
12.15.5 RECENT DEVELOPMENT 142
12.16 KONINKLIJKE PHILIPS N.V. 143
12.16.1 COMPANY SNAPSHOT 143
12.16.2 REVENUE ANALYSIS 143
12.16.3 COMPANY SHARE ANALYSIS 144
12.16.4 PRODUCT PORTFOLIO 144
12.16.5 RECENT DEVELOPMENT 144
12.17 MASIMO 145
12.17.1 COMPANY SNAPSHOT 145
12.17.2 REVENUE ANALYSIS 145
12.17.3 COMPANY SHARE ANALYSIS 146
12.17.4 PRODUCT PORTFOLIO 146
12.17.5 RECENT DEVELOPMENT 146
12.18 NETEERA 147
12.18.1 COMPANY SNAPSHOT 147
12.18.2 PRODUCT PORTFOLIO 147
12.18.3 RECENT DEVELOPMENT 147
12.19 NIHON KOHDEN CORPORATION 148
12.19.1 COMPANY SNAPSHOT 148
12.19.2 REVENUE ANALYSIS 148
12.19.3 COMPANY SHARE ANALYSIS 149
12.19.4 PRODUCT PORTFOLIO 149
12.19.5 RECENT DEVELOPMENT 149
12.20 OMRON CORPORATION 150
12.20.1 COMPANY SNAPSHOT 150
12.20.2 REVENUE ANALYSIS 150
12.20.3 COMPANY SHARE ANALYSIS 151
12.20.4 PRODUCT PORTFOLIO 151
12.20.5 RECENT DEVELOPMENT 151
12.21 SENSEONICS, INC. 152
12.21.1 COMPANY SNAPSHOT 152
12.21.2 REVENUE ANALYSIS 152
12.21.3 COMPANY SHARE ANALYSIS 153
12.21.4 PRODUCT PORTFOLIO 153
12.21.5 RECENT DEVELOPMENT 153
12.22 VITALCONNECT 154
12.22.1 COMPANY SNAPSHOT 154
12.22.2 PRODUCT PORTFOLIO 154
12.22.3 RECENT DEVELOPMENT 154
12.23 VITLS 155
12.23.1 COMPANY SNAPSHOT 155
12.23.2 PRODUCT PORTFOLIO 155
12.23.3 RECENT DEVELOPMENT 155
12.24 VIVIFY HEALTH INC. 156
12.24.1 COMPANY SNAPSHOT 156
12.24.2 PRODUCT PORTFOLIO 156
12.24.3 RECENT DEVELOPMENTS 156
12.25 WITHINGS 157
12.25.1 COMPANY SNAPSHOT 157
12.25.2 COMPANY SHARE ANALYSIS 157
12.25.3 PRODUCT PORTFOLIO 157
12.25.4 RECENT DEVELOPMENT 158
13 QUESTIONNAIRE 159
14 RELATED REPORTS 162

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

Data Bridge Market Research 社の最新刊レポート

本レポートと同じKEY WORD（industry）の最新刊レポート


よくあるご質問


Data Bridge Market Research社はどのような調査会社ですか?


データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/09　10:27

143.78 円

159.73 円

191.51 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.